These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16386408)

  • 1. Psychiatric side effects of interferon-beta in multiple sclerosis.
    Goeb JL; Even C; Nicolas G; Gohier B; Dubas F; Garré JB
    Eur Psychiatry; 2006 Apr; 21(3):186-93. PubMed ID: 16386408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis.
    Patten SB; Francis G; Metz LM; Lopez-Bresnahan M; Chang P; Curtin F
    Mult Scler; 2005 Apr; 11(2):175-81. PubMed ID: 15794391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute delirium, delusion, and depression during IFN-beta-1a therapy for multiple sclerosis: a case report.
    Goëb JL; Cailleau A; Lainé P; Etcharry-Bouyx F; Maugin D; Duverger P; Gohier B; Rannou-Dubas K; Dubas F; Garré JB
    Clin Neuropharmacol; 2003; 26(1):5-7. PubMed ID: 12567157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis.
    Fragoso YD; Frota ER; Lopes JS; Noal JS; Giacomo MC; Gomes S; Gonçalves MV; da Gama PD; Finkelsztejn A
    Clin Neuropharmacol; 2010; 33(6):312-6. PubMed ID: 21079457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis, interferon beta-1b and depression A prospective investigation.
    Feinstein A; O'Connor P; Feinstein K
    J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis.
    Lana-Peixoto MA; Teixeira AL; Haase VG
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):721-4. PubMed ID: 12364937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment.
    Alba Palé L; León Caballero J; Samsó Buxareu B; Salgado Serrano P; Pérez Solà V
    Mult Scler Relat Disord; 2017 Oct; 17():138-143. PubMed ID: 29055445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritis during interferon beta-1b treatment in multiple sclerosis.
    Altintas A; Alici Y; Melikoğlu M; Siva A
    Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis beyond EDSS: depression and fatigue.
    Ziemssen T
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S37-41. PubMed ID: 19200865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.
    Strueby L; Nair B; Kirk A; Taylor-Gjevre RM
    Scand J Rheumatol; 2005; 34(6):485-8. PubMed ID: 16393774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S; Rahimi R; Abdollahi M
    Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis.
    Mohr DC; Likosky W; Dwyer P; Van Der Wende J; Boudewyn AC; Goodkin DE
    Arch Neurol; 1999 Oct; 56(10):1263-5. PubMed ID: 10520943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Affective and psychotic disorders in multiple sclerosis].
    Pozuelo-Moyano B; Benito-León J
    Rev Neurol; 2015 Dec; 61(11):503-8. PubMed ID: 26602805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk of affective disorder in multiple sclerosis].
    Stenager EN; Stage KB; Stenager E
    Ugeskr Laeger; 2011 Jan; 173(2):123-6. PubMed ID: 21219844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta-1a overdose in a multiple sclerosis patient.
    Falcone NP; Nappo A; Neuteboom B
    Ann Pharmacother; 2005 Nov; 39(11):1950-2. PubMed ID: 16204396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological aspects of multiple sclerosis.
    José Sá M
    Clin Neurol Neurosurg; 2008 Nov; 110(9):868-77. PubMed ID: 18022759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Certain problems of therapy with beta-interferon preparations].
    Gusev EI; Demina TL; Boĭko AN; Khachanova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):98-102. PubMed ID: 12938643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in multiple sclerosis associated with interferon beta-1a (Rebif).
    Pandya R; Patten S
    Can J Psychiatry; 2002 Sep; 47(7):686. PubMed ID: 12355685
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug induced liver injury secondary to interferon-beta (IFN-beta) in multiple sclerosis.
    Byrnes V; Afdhal N; Challies T; Greenstein PE
    Ann Hepatol; 2006; 5(1):56-9. PubMed ID: 16531969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.